Carlos André dos Santos-Silva

Dr. Carlos André dos Santos-Silva

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
VAVinícius Costa Amador
Vinícius Costa Amador
CSCarlos André dos Santos-Silva
Carlos André dos Santos-Silva
LVLívia Maria Batista Vilela
Lívia Maria Batista Vilela
MOMarx Oliveira-Lima
Marx Oliveira-Lima
MRMireli de Santana Rêgo
Mireli de Santana Rêgo
ABAna Benko-Iseppon
Ana Benko-Iseppon
Lipid transfer proteins (LTPs) are among the most promising plant-exclusive antimicrobial peptides (AMPs). They figure among the most challenging AMPs from the point of view of their structural diversity, functions and biotechnological applications. This review presents a current picture of the LTP research, addressing not only their structural, evolutionary and further predicted functional aspects. Traditionally, LTPs have been identified by their direct isolation by biochemical techniques, whereas omics data and bioinformatics deserve special attention for their potential to bring new insights. In this context, new possible functions have been identified revealing that LTPs are actually multipurpose, with many additional predicted roles. Despite some challenges due to the toxicity and allergenicity of LTPs, a systematic review and search in patent databases, indicate promising perspectives for the biotechnological use of LTPs in human health and also plant defense.

5 August 2020 in Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
RMRonald Rodrigues de Moura
Ronald Rodrigues de Moura
Almerinda AgrelliAlmerinda Agrelli
Almerinda Agrelli
CSCarlos André dos Santos-Silva
Carlos André dos Santos-Silva
NSNatália Silva
Natália Silva
BABruno Rodrigo Assunção
Bruno Rodrigo Assunção
Sergio CrovellaSergio Crovella
Sergio Crovella
Aims Brazil is nowadays one of the epicentres of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and new therapies are needed to face it. In the context of specific immune response against the virus, a correlation between Major Histocompatibility Complex Class I (MHC-I) and the severity of the disease in patients with COVID-19 has been suggested. Aiming at better understanding the biology of the infection and the immune response against the virus in the Brazilian population, we analysed SARS-CoV-2 protein S peptides in order to identify epitopes able to elicit an immune response mediated by the most frequent MHC-I alleles using in silico methods. Methods Our analyses consisted in searching for the most frequent Human Leukocyte Antigen (HLA)-A, HLA-B and HLA-C alleles in the Brazilian population, excluding the genetic isolates; then, we performed: molecular modelling for unsolved structures, MHC-I binding affinity and antigenicity prediction, peptide docking and molecular dynamics of the best fitted MHC-I/protein S complexes. Results We identified 24 immunogenic epitopes in the SARS-CoV-2 protein S that could interact with 17 different MHC-I alleles (namely, HLA-A*01:01; HLA-A*02:01; HLA-A*11:01; HLA-A*24:02; HLA-A*68:01; HLA-A*23:01; HLA-A*26:01; HLA-A*30:02; HLA-A*31:01; HLA-B*07:02; HLA-B*51:01; HLA-B*35:01; HLA-B*44:02; HLA-B*35:03; HLA-C*05:01; HLA-C*07:01 and HLA-C*15:02) in the Brazilian population. Conclusions Being aware of the intrinsic limitations of in silico analysis (mainly the differences between the real and the Protein Data Bank (PDB) structure; and accuracy of the methods for simulate proteasome cleavage), we identified 24 epitopes able to interact with 17 MHC-I more frequent alleles in the Brazilian population that could be useful for the development of strategic methods for vaccines against SARS-CoV-2.

1 July 2021 in Biochimie
Verified
Journal Article
Closed access
CSCarlos André dos Santos-Silva
Carlos André dos Santos-Silva
LVLívia Maria Batista Vilela
Lívia Maria Batista Vilela
RSRoberta Lane de Oliveira Silva
Roberta Lane de Oliveira Silva
JSJéssica Barboza da Silva
Jéssica Barboza da Silva
AMAlexandre Reis Machado
Alexandre Reis Machado
ABAna Benko-Iseppon
Ana Benko-Iseppon

7 August 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
LZLuisa Zupin
Luisa Zupin
CSCarlos André dos Santos-Silva
Carlos André dos Santos-Silva
AMAya R. Hamad Al Mughrbi
Aya R. Hamad Al Mughrbi
LVLivia Maria Batista Vilela
Livia Maria Batista Vilela
ABAna Benko-Iseppon
Ana Benko-Iseppon
Sergio CrovellaSergio Crovella
Sergio Crovella
Zoonoses have recently become the center of attention of the general population and scientific community. Notably, more than 30 new human pathogens have been identified in the last 30 years, 75% of which can be classified as zoonosis. The complete eradication of such types of infections is far out of reach, considering the limited understanding of animal determinants in zoonoses and their causes of emergence. Therefore, efforts must be doubled in examining the spread, persistence, and pathogenicity of zoonosis and studying possible clinical interventions and antimicrobial drug development. The search for antimicrobial bioactive compounds has assumed great emphasis, considering the emergence of multi-drug-resistant microorganisms. Among the biomolecules of emerging scientific interest are antimicrobial peptides (AMPs), potent biomolecules that can potentially act as important weapons against infectious diseases. Moreover, synthetic AMPs are easily tailored (bioinformatically) to target specific features of the pathogens to hijack, inducing no or very low resistance. Although very promising, previous studies on SAMPs’ efficacy are still at their early stages. Indeed, further studies and better characterization on their mechanism of action with in vitro and in vivo assays are needed so as to proceed to their clinical application on human beings.

28 July 2025 in Viruses
Verified
Journal Article
Open access
PDF file
FAFernanda Alves de Andrade
Fernanda Alves de Andrade
Madson Allan de Luna-AragãoMadson Allan de Luna-Aragão
Madson Allan de Luna-Aragão
JFJosé Diogo Cavalcanti Ferreira
José Diogo Cavalcanti Ferreira
FSFernanda Freitas Souza
Fernanda Freitas Souza
Ana Carolina dá Rocha OliveiraAna Carolina dá Rocha Oliveira
Ana Carolina dá Rocha Oliveira
VPVALESCA PANDOLFI
VALESCA PANDOLFI
Cowpea (Vigna unguiculata) is a crop of significant socioeconomic importance, particularly in the semi-arid regions of Africa and America. However, its productivity has been adversely affected by viral diseases, including the cowpea aphid-borne mosaic virus (CABMV), a single-stranded RNA virus. It is known that the VPg protein interacts with the host’s translation initiation factor (eIF4E), promoting viral replication. This study aimed to investigate the relationship between mutations in the cowpea eIF4E gene and resistance to CABMV. Twenty-seven cultivars were screened by PCR and bioassays for presence/absence of mutations associated with resistance or susceptibility to Potyviruses. Of the cultivars with mutations previously associated with susceptibility, 88.24% exhibited viral symptoms, while 62.5% associated with resistance remained asymptomatic. The in silico analyses revealed that non-synonymous mutations (Pro68Arg, Gly109Arg) alter the structure of the eIF4E protein, reducing its affinity to VPg. Molecular dynamics simulations also pointed to an enhanced structural stability of eIF4E in resistant cultivars and reinforced, for the first time, key mutations and the functional role of the eIF4E gene in resistance to CABMV in cowpea. Our results offer valuable insights for virus disease management and for genetic improvement programs for this important crop.

11 January 2026 in Revista JRG de Estudos Acadêmicos
Verified
Journal Article
Open access
LNLuiz Carlos Silva Dias Neto
Luiz Carlos Silva Dias Neto
CSCarlos André dos Santos-Silva
Carlos André dos Santos-Silva
LVLívia Maria Batista Vilela
Lívia Maria Batista Vilela
A resistência antimicrobiana representa um dos principais desafios contemporâneos para a saúde pública global, impulsionando a busca por novas moléculas bioativas com potencial terapêutico. Entre as alternativas promissoras, destacam-se os peptídeos antimicrobianos (AMPs) de origem vegetal, especialmente as defensinas, devido à sua ampla atividade antimicrobiana, elevada estabilidade estrutural e potencial biotecnológico. Neste estudo, foi aplicado um pipeline bioinformático para prospecção in silico de peptídeos do tipo defensina no proteoma de Handroanthus impetiginosus. Inicialmente, foi construído um banco de referência contendo 392 defensinas vegetais previamente caracterizadas, obtidas no UniProt, utilizado posteriormente em análises de similaridade por BLASTp contra o proteoma completo da espécie. As análises resultaram na identificação de 4.819 sequências com similaridade a defensinas vegetais, as quais foram submetidas à filtragem estrutural por meio da identificação de domínios conservados utilizando o Batch CD-Search. Essa etapa permitiu selecionar 18 sequências contendo domínios característicos de defensinas, incluindo Gamma-thionin, Knot-1, Knot-1 superfamily e Defensin-like. A caracterização físico-química revelou predominância de proteínas com caráter catiônico, elevados valores de ponto isoelétrico e índices GRAVY negativos, compatíveis com propriedades típicas de AMPs. A predição de peptídeos sinal reduziu o conjunto para sete sequências com arquitetura compatível com defensinas maduras secretadas. Todas as sequências selecionadas foram classificadas como peptídeos antimicrobianos com probabilidade máxima pelo Antimicrobial Peptide Scanner v2. Adicionalmente, as análises estruturais realizadas no HeliQuest evidenciaram hidrofobicidade moderada e organização anfipática compatível com interação com membranas biológicas. Em conjunto, os resultados demonstram que o proteoma de H. impetiginosus representa uma fonte promissora de defensinas vegetais com potencial antimicrobiano. Além disso, a estratégia computacional empregada mostrou-se eficiente para identificação e priorização de candidatos biologicamente plausíveis, fornecendo uma base robusta para futuras validações experimentais e aplicações biotecnológicas.